Application of miRNA sponge for miR-23b in GBM was found to reduce tumor malignancy, through the downregulation of HIF-1α, VEGF, and other molecules, suggesting miR-23 as a promising anticancer therapy either alone or in combination with current targeted therapies [118] (Table 6). This evidence concerns the gene HIF1A and neoplasm.